180 related articles for article (PubMed ID: 30288659)
1. Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
Cho SY; Kim S; Son MJ; Rou WS; Kim SH; Eun HS; Lee BS
Dig Dis Sci; 2019 Jan; 64(1):123-136. PubMed ID: 30288659
[TBL] [Abstract][Full Text] [Related]
2. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.
Cao MQ; You AB; Cui W; Zhang S; Guo ZG; Chen L; Zhu XD; Zhang W; Zhu XL; Guo H; Deng DJ; Sun HC; Zhang T
FASEB J; 2020 Apr; 34(4):5892-5905. PubMed ID: 32157720
[TBL] [Abstract][Full Text] [Related]
3. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma.
Fu B; Meng W; Zeng X; Zhao H; Liu W; Zhang T
Biomed Res Int; 2017; 2017():4698167. PubMed ID: 28536696
[TBL] [Abstract][Full Text] [Related]
4. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
[TBL] [Abstract][Full Text] [Related]
5. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.
Deroo BJ; Hewitt SC; Peddada SD; Korach KS
Endocrinology; 2004 Dec; 145(12):5485-92. PubMed ID: 15345672
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
Lü Y; Zhang J; Li L; Li S; Yang Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma.
Jin XL; Lian JR; Guan YH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8197-8202. PubMed ID: 30556858
[TBL] [Abstract][Full Text] [Related]
9. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.
Cadenas C; Franckenstein D; Schmidt M; Gehrmann M; Hermes M; Geppert B; Schormann W; Maccoux LJ; Schug M; Schumann A; Wilhelm C; Freis E; Ickstadt K; Rahnenführer J; Baumbach JI; Sickmann A; Hengstler JG
Breast Cancer Res; 2010; 12(3):R44. PubMed ID: 20584310
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
Xu W; Rao Q; An Y; Li M; Zhang Z
PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Oct; 18(39):5581-8. PubMed ID: 23112551
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
[TBL] [Abstract][Full Text] [Related]
16. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
18. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
19. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
